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Context: The experimental paradigm of acute caloric restriction (CR) followed by refeeding (RF) can
be used to study the homeostatic mechanisms that regulate energy homeostasis, which are relevant
to understanding the adaptive response to weight loss.
Objective: Metabolomics, the measurement of hundreds of small molecule metabolites, their
precursors, derivatives, and degradation products, has emerged as a useful tool for the study of
physiology and disease and was used here to study the metabolic response to acute CR.
Participants, Design, and Setting: We used four ultra high-performance liquid chromatography-
tandem mass spectrometry methods to characterize changes in carbohydrates, lipids, amino acids,
and steroids in eight normal weight men at baseline, after 48 hours of CR (10% of energy
requirements) and after 48 hours of ad libitum RF in a tightly controlled environment.
Results: We identified a distinct metabolomic signature associated with acute CR characterized by
the expected switch from carbohydrate to fat utilization with increased lipolysis and b-fatty acid
oxidation.We found an increase inv-fatty acid oxidation and levels of endocannabinoids, which are
known to promote food intake. These changes were reversed with RF. Several plasmalogen
phosphatidylethanolamines (endogenous antioxidants) significantly decreased with CR (all P #
0.0007). Additionally, acute CR was associated with an increase in the branched chain amino acids
(all P # 1.4 3 1027) and dehydroepiandrosterone sulfate (P = 0.0006).
Conclusions: We identified a distinct metabolomic signature associated with acute CR. Further
studies are needed to characterize the mechanisms that mediate these changes and their potential
contribution to the adaptive response to dietary restriction. (J Clin Endocrinol Metab 102:
4486–4495, 2017)
The adipocyte-derived hormone leptin circulates atconcentrations proportional to fat mass in weight-
stable humans and is a pivotal regulator of energy ho-
meostasis (1–3). Most individuals maintain a relatively
stable body weight over long periods of time despite day-
to-day fluctuations in the number of calories consumed
and the amount of physical activity undertaken. Loss of
fat mass leads to a fall in circulating leptin concentrations
triggering changes in energy intake, energy expenditure,
and neuroendocrine function that restore energy ho-
meostasis, resulting in rebound weight gain—the phe-
nomenon popularly known as yo-yo dieting. Rosenbaum
et al. (4, 5) have shown that leptin administration in
short-term human studies can reverse many of the
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consequences of weight loss (a state of partial leptin
deficiency). However, recombinant leptin/leptinmimetics
are not currently available for this purpose. The identi-
fication of additional markers of the homeostatic re-
sponse to weight loss could inform therapeutic strategies
to prevent weight regain and aid weight maintenance.
In seminal studies in mice, Ahima et al. (6) showed
that, as well as being a marker of fat mass, leptin acts as a
signal of nutrient availability; acute caloric restriction
(CR)/starvation (without loss of fat mass) leads to a rapid
fall in circulating leptin concentration, hyperphagia, re-
duced energy expenditure, and hypogonadism (6), fea-
tures that mimic genetic leptin deficiency in rodents and
humans (7, 8) and can be normalized by leptin admin-
istration (6, 9). Acute CR in humans can therefore be used
as a model for investigating leptin-mediated homeostatic
responses without the potential confounding effects of
weight loss.
Themetabolomic profile at a given time point represents
the cumulative effects of the diet, genome, transcriptome,
proteome, and gut microbiome–host interaction on small
molecule metabolites whose concentrations change rapidly
(10). Bymeasuring themetabolome in the same individuals
before and after a precise perturbation, our aim was to
identify themetabolites that change significantlywith acute
CR and refeeding (RF). We assessed the short-term ad-
aptation to CR to avoid confounding with metabolic
changes related to weight loss.
We performed a carefully controlled experimental
study to directly examine the effects of acute CR in eight
normal weight young men housed in a clinical research
facility where diet, fluid intake, timing of meals, and
sleep were precisely controlled and monitored (Sup-
plemental Table 1). Fasting blood samples were ob-
tained at three time points: baseline (after 24 hours of
feeding to normal energy requirements); after 48 hours
of CR to 10% of their normal energy requirements
[mean 6 standard error of the mean (SEM), 226 6
5 kcal/d]; after 48 hours of ad libitum RF to allow for
energy homeostasis to be reset. Critically, the pro-
portion of macronutrients received during CR was the
same as on the baseline day (50% carbohydrate, 30%
fat, 20% protein). In a previous study, we have shown
that this experimental manipulation is sufficient to
significantly alter physiological parameters including
autonomic function, neuroendocrine hormone secre-
tion, and the sleep/wake cycle (11). Here, in addition to
measuring circulating hormones andpeptides predicted to
be altered by nutritional status (e.g., leptin, insulin, gluca-
gon, and thyroid hormones), we used a high throughput
metabolomics assay employing four independent ultra
high-performance liquid chromatography-tandem mass
spectrometry (UPLC-MS/MS) methods to measure 770
small molecule metabolites involved in carbohydrate, fat,
protein, and steroid metabolism.
Material and Methods
Experimental design of study
The study was approved by the Cambridge local research
ethics committee and was conducted in accordance with the
principles of the Declaration of Helsinki. Written informed
consent was received from each participant prior to inclusion
in the study. We recruited eight normal weight healthy men
using the following inclusion criteria: normal glucose toler-
ance measured by a 75-g oral glucose tolerance test, no ev-
idence of renal, liver, or thyroid disease, average alcohol
intake ,2 units/d, not participating in an organized exercise
program, not treated with anorectic agents or medications
known to affect carbohydrate and/or lipid metabolism, or blood
pressure. Shift workers were excluded from the study; all par-
ticipants had a normal sleep/wake pattern as determined by
polysomnography at screening. Weight and height were mea-
sured barefoot in light clothing and body mass index calculated
(weight in kg/height in meters squared). Baseline characteristics
are provided in Supplemental Table 1.
Participants were resident on the National Institute for
Health Research-Wellcome Trust Clinical Research Facility,
Addenbrooke’s Hospital, Cambridge, United Kingdom, for the
duration of the study under direct observation throughout. At
baseline, volunteers consumed a balanced diet (50% carbo-
hydrate, 30% fat, and 20%protein) matching their daily energy
requirement calculated by the basal metabolic rate multiplied
by a physical activity level of 1.25 using the Schofield Equation
(12). To manipulate energy balance, baseline measurements
were followed by CR to 10% of normal energy requirement
(mean 6 SEM, 226 6 5 kcal/d) for 2 days. After CR, partici-
pants were offered three substantial ad libitum buffet meals per
day (20 MJ = 4777 kcal) and additional snacks (16 MJ =
3821 kcal) between meals for 2 days. They were invited to eat
freely until comfortably full; food consumption was covertly
measured. Fluid intake was fixed for all participants; no coffee/
tea/alcohol was permitted. All meals were given at the same time
each day. Timing of “lights out” and waking were controlled.
We collected fasting serum and plasma samples at 0800 AM at
baseline, after CR, and RF.
Biochemical assays
Plasma glucose, insulin, glucagon, leptin, serum lipids,
thyrotropin, free thyroxine (T4), and free tri-iodothyronine
(T3) were measured. Testosterone and dehydroepiandrosterone
sulfate (DHEAS) were measured with a DiaSorin Liaison XL
analyzer (Saluggia, Italy), and3-hydroxybutyrate using the Stanbio
colorimetric kit (Boerne, TX). Blood samples were collected in the
fasting state at 08:00 AM.
Metabolomic platform
The nontargeted metabolomic analysis was performed at
Metabolon, Inc. (Durham, NC). All serum samples were stored
at 280°C until processed. The detailed descriptions of the
platform, including sample processing, instrument configu-
ration, data acquisition, and metabolite identification and
quantitation, were published previously (10) with the ex-
ception that four independent UPLC-MS/MS methods were
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used. The samples were extracted with methanol, and the
supernatants were divided into five equal fractions for
analysis by UPLC-MS/MS: (1) reverse phase (RP) UPLC-MS/
MS method with positive ion mode electrospray ionization
(ESI), optimized for more hydrophilic compounds. In this
method, the extract was gradient eluted from a C18 column
(Waters UPLC BEH C18-2.13 100 mm, 1.7 mm) using water
and methanol, containing 0.05% perfluoropentanoic acid
and 0.1% formic acid; (2) RP/UPLC-MS/MS method with
positive ion mode ESI, optimized for more hydrophobic
compounds. In this method, the extract was gradient eluted
from the same aforementioned C18 column using methanol,
acetonitrile, water, 0.05% perfluoropentanoic acid, and
0.01% formic acid and was operated at an overall higher
organic content; (3) RP/UPLC-MS/MS method with negative
ion mode ESI. In this method, the extract was gradient eluted
from the column using methanol and water; however, with
6.5 mM ammonium bicarbonate at pH 8; (4) hydrophilic
interaction liquid chromatography/UPLC-MS/MS with nega-
tive ion mode ESI. In this method, the extract was gradient
eluted using water and acetonitrile with 10 mM ammonium
formate, pH 10.8; and (5) reserved for backup. For UPLC-MS/
MS, all methods used a Waters ACQUITY UPLC (Waters
Corp., Milford, MA) and a Thermo Scientific Q-Exactive high
resolution/accurate mass spectrometer (Thermo Fisher Scien-
tific, Waltham,MA) interfaced with a heated ESI-II source and
Orbitrap mass analyzer operated at 35,000 mass resolution.
All the methods alternated between full scan mass spectrom-
etry (MS) and data-dependent MSn scans using dynamic ex-
clusion. The scan range varied slighted between methods but
generally covered 70 to 1000 m/z.
The structure of metabolites was identified by automated
comparison of the ion features in the experimental samples to a
reference library of chemical standard entries that included
retention time, molecular weight (m/z), preferred adducts, and
in-source fragments, as well as associated MS spectra and cu-
rated by visual inspection for quality control using software
developed at Metabolon (13–15).
Statistical analyses
Statistical analyses of biochemistry results
Log-transformed values were analyzed using analysis of
variance with repeated measures to test for within-subject
changes across the three study conditions (baseline, CR, RF).
The within-subjects P value was adjusted using the Greenhouse-
Geisser correction factor for lack of sphericity. Pairwise
comparisons of the three study conditions were performed by two-
sided Student t test when appropriate. A P value of 0.05 was
considered significant after Bonferroni correction for multiple
comparisons.
Statistical analyses of metabolite
semiquantitative levels
Following scaling of the ion count (so that the median
equals 1), imputation of any missing values with the minimum
observed value for each metabolite and log transformation,
analysis of variance contrasts and Welch matched-pair t tests
were used to identify biochemicals that differed significantly
between experimental groups. Multiple comparisons were
accounted for with the false discovery rate method (16). An
estimate of the false discovery rate (q value) was calculated to
take into account the multiple comparisons that normally
occur in metabolomic-based studies. A low q value (q , 0.10)
is an indication of high confidence in a result. Although a
higher q value indicates diminished confidence, it does not
necessarily rule out the significance of a result. Principal
component analysis (PCA) and hierarchical clustering of
scaled, imputed, and log-transformed metabolite levels are
detailed in the Supplemental Methods. Statistical analyses
were performed using JMP (SAS Institute, Inc., Cary, NC) and
R software (R Foundation, Vienna, Austria).
Results
A metabolomic signature of CR
Acute CR was associated with a significant fall in cir-
culating fasting leptin, insulin, and glucose concentrations
and an increase in glucagon levels (Table 1). We noted a
decrease in free T3 but no significant change in thyrotropin
or free T4 in response to acute CR as seen in some previous
studies (17, 18). Most parameters returned to baseline
values with RF, whereas others (insulin, glucagon) were
sensitive to the overconsumption of calories on ad libitum
RF and exceeded baseline values (Table 1).
We explored the metabolomic profile for each partici-
pant at baseline, CR, and in the refed state by employing
multivariate statistical analyses to analyze state-dependent
changes. PCA was conducted on log-transformed metab-
olite levels to identify whether aggregated values of specific
components could account for a proportion of the vari-
ability between baseline, CR, and RF. We found that the
PCA of the metabolome completely distinguished the three
states revealing a characteristic metabolomic signature as-
sociated with CR (Fig. 1A). While within a state, there was
variability between participants (presumably due to genetic/
biological factors), the magnitude and direction of effect of
CR and RF was comparable for all participants (Supple-
mental Fig. 1).
A substantial proportion of the entire metabolome
exhibited a dynamic response to CR and RF (Fig. 1B).We
used hierarchical clustering to identify large-scale dif-
ferences in metabolite categories for each individual in
each state. The resulting heatmap revealed that CR
induced a number of changes in lipid and carbohydrate
utilization; some of which were reversed upon RF
(Fig. 1C). Further discussion is focused on metabolites
that constitute this dynamic metabolomic signature. The
complete data set is presented in Supplemental Table 2
and an associated interactive webpage is available (www.
goos.org.uk).
Carbohydrate utilization: glycolysis and the
tricarboxylic acid cycle
Classically, glycolysis converts glucose to pyruvate,
which, under aerobic conditions, is converted into acetyl-
CoA, the entry point into the tricarboxylic acid (TCA)
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cycle (Fig. 2A). As expected, CR was associated with a
decrease in glucose (fold change 0.84, P = 5.9 3 1025)
and pyruvate (fold change 0.32, P = 9.0 3 1024), which
were restored byRF (fold change 1.14 and 10.8,P = 8.03
1024 and 1.23 1027, respectively) (Fig. 2A). Citrate and
aconitate were significantly elevated with CR, there was
no change in isocitrate or a-ketoglutarate, but a signif-
icant decrease in succinylcarnitine, an intermediate
arising reversibly from succinyl-CoA (Fig. 2A). N-acetyl
derivatives of the glucogenic amino acids glycine,
serine, and alanine increased with CR and decreased
with RF (Fig. 2B). In contrast, glutamate and its product
N-acetylglutamate decreased with CR (Fig. 2B). These
changes reversed uponRF and collectively are consistent
with an increase in metabolite flux through the TCA
cycle in response to CR.
Although some N-acetylated amino acid derivatives
followed the same pattern across baseline–CR–RF condi-
tions as their corresponding amino acids (e.g., glutamate,
serine), others did not (e.g., glycine, alanine; Fig. 2B). The
reasons for the differential effects of CR onN-acetylation of
gluconeogenic amino acids need further investigation.
Lipolysis and fatty acid oxidation
CR was characterized by lipolysis of triglycerides gen-
erating increased levels of glycerol (2.43-fold, P = 0.0003),
decreased monoacylglycerols, and an increase of all long
and most medium chain fatty acids detected (Fig. 3A–3C).
During CR, we found a significant increase in long-chain
acylcarnitines, which shuttle fatty acids into mitochondria
(Fig. 3D). Consequently, the ketone bodies acetoace-
tate and 3-hydroxybutyrate, final products of the fatty
acid b-oxidation pathway, were markedly increased with
CR (P = 1.6 3 10211 and P = 2.0 3 10211, respectively)
and decreased with RF (P = 4.93 10213 and 1.63 10212,
respectively) (Fig. 3E). Serum levels of ketone bodies
were measured in routine laboratory tests for comparison;
3-hydroxybutyrate increased 17.3-fold (Table 1).
Additionally, 3-hydroxy fatty acids were increased in
keeping with increased lipolysis and fatty acid b-oxidation
(Fig. 3F). Furthermore, fatty acid dicarboxylates, in par-
ticular dodecanedioate and tetradecanedioate, which in-
creased 7.7-fold on CR, are generated through the
v-oxidation pathway (Fig. 3F). Although this pathway has
rarely been studied in humans, our study suggests that
activation of v-oxidation may occur when b-oxidation
becomes overwhelmed as it may in CR. Taken together,
CR resulted in increased reliance on fatty acid (rather than
carbohydrate) metabolism to fuel energy production.
RF led to a decreased reliance on fatty acid oxidation
to meet energetic needs and stimulation of lipogen-
esis (Fig. 3B–3F).
Table 1. Changes in Fasting Biochemistry in CR and Upon RF
Mean (SEM) Baseline CR RF
P Values for Overall Comparison
Overall BL-CR CR-RF BL-RF
Caloric intake, kcal/d 2255 (53) 226 (5) 4552 (324) ,0.0001 ,0.001 ,0.001 ,0.001
Glucose metabolisma
Glucose, mmol/L 4.74 (0.12) 3.48 (0.08) 4.70 (0.11) ,0.0001 ,0.001 ,0.001 1.00
Insulin, pmol/L 44.6 (7.7) 14.6 (2.6) 87.6 (14.2) ,0.0001 ,0.001 ,0.001 ,0.001
Glucagon, pg/mL 24.8 (2.7) 74.7 (11.6) 38.2 (4.2) 0.0001 ,0.001 ,0.001 0.01
3-OH butyrate, mmol/L 101.8 (7.8) 1763 (258) 93.7 (7.4) ,0.0001 ,0.001 ,0.001 1.00
Leptin, ng/mL 3.26 (0.81) 0.66 (0.19) 4.55 (1.34) ,0.0001 ,0.001 ,0.001 0.22
Lipid metabolismb
Total cholesterol, mmol/L 4.11 (0.34) 4.30 (0.29) 3.73 (0.27) 0.0009 0.18 ,0.001 0.006
Triglycerides, mmol/L 1.31 (0.11) 1.24 (0.10) 1.52 (0.14) 0.10
Thyroid functionc
TSH, mU/L 1.34 (0.18) 1.14 (0.19) 2.00 (0.29) 0.006 0.20 0.001 0.04
Free T4, pmol/L 13.93 (0.35) 14.80 (0.51) 14.94 (0.47) 0.03 0.07 1.00 0.03
Free T3, pmol/L 5.02 (0.19) 3.92 (0.17) 4.65 (0.28) 0.001 ,0.001 0.002 0.12
Steroidsc
Testosterone, nmol/L 18.51 (2.10) 17.05 (2.52) 15.27 (2.12) 0.10
DHEAS, mg/dL 312.2 (43.8) 347.1 (39.9) 298.6 (49.7) 0.10
Data are presented as mean (SEM). We tested the correlation of biochemistry assay concentrations with levels measured by metabolomics; the Pearson
correlation ranged between r = 0.87 and r = 0.95 (for glucose, 3-OH butyrate and DHEAS) but was lower for cholesterol (r = 0.70; the metabolomics
platform measures free cholesterol, whereas the standard clinical assay measures total cholesterol) and free T4 (r = 0.50).
Abbreviations: 3-OH butyrate, 3-hydroxybutyrate; BL, baseline; TSH, thyroid-stimulating hormone.
aTo convert glucose values tomilligrams per deciliter,multiply by 18. To convert 3-OHbutyrate values tomilligrams per deciliter, divide by 96.09. Reference
ranges for insulin: 0 to 60 pmol/L; 3-OH butyrate: 20 to 270 mmol/L.
bTo convert lipid values to milligrams per deciliter, multiply by 38.7 for total cholesterol and 88.5 for triglycerides.
cReference ranges for TSH:0.35 to5.5mU/L; freeT4:10.0 to19.8pmol/L; freeT3:3.5 to6.5pmol/L; testosterone: 8.0 to29.0nmol/L;DHEAS:161.2 to561.6mg/dL.
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Phospholipids and endocannabinoids
Although triglycerides represent the major source of
stored lipid, phospholipids are the major constituents
of plasma membrane lipids and eicosanoids, such as
prostaglandins, leukotrienes, and thromboxanes. We
found that most glycerophospholipids and their product
lysolipids were decreased in CR and increased upon RF
(Fig. 4A–4C). Plasmalogens are a subclass of glycer-
ophospholipids that serve as endogenous antioxi-
dants, protecting membrane lipids and lipoprotein
particles from excessive oxidation by scavenging re-
active oxygen species via the vinyl ether moiety (19,
20). Interestingly, the plasmalogen phosphatidyleth-
anolamines, but not the plasmalogen phosphatidyl-
cholines, decreased on CR and increased with RF
(Fig. 4B).
Sphingolipids play a role in the formation of membrane
lipid rafts, are components of plasma lipoprotein associated
particles, and act as ligands for specific cell-surface re-
ceptors. In our study, the most abundant sphingolipids,
the sphingomyelins, increased with CR; this pattern
was reversed in the refed state (Fig. 4D). Sphingosine,
sphingosine-1-phosphate, and ceramides are interconvert-
ible sphingolipidmetabolites;many studies have shown that
their relative levels regulate cell fate (21, 22). Levels of
sphingosine (generally associated with growth arrest and
cell death) decreased in CR (0.52-fold, P = 0.03), whereas
there was no change in sphingosine-1-phosphate, which is
involved in cell growth and survival.
Another group of lipid signaling molecules, the
endocannabinoids, modulate energy intake and expen-
diture by acting on central neural pathways expressing
the cannabinoid 1 receptor, a target of the weight-loss
agent rimonabant (23). Although there was no change in
2-arachidonoyl glycerol, the most abundant endogenous
ligand of cannabinoid receptors, which has a very short
Figure 1. Metabolomic signature of CR. Seven hundred seventy metabolites were measured in eight subjects at three time points: baseline
(gray), after CR (black), and upon RF (white). (A) The PCA; principal component 1 (PC1) captured 38.5% of the variance of the data set and
discriminated well between the three study conditions, whereas component 2 (PC2) covered 9.4% of the variance. (B and C) Changes in
metabolite categories: amino acids (dark orange), peptides (light orange), carbohydrates (red), energy and the tricarboxylic acid (TCA) cycle (pink),
lipids (dark green), nucleotides (light green), cofactors and vitamins (dark blue), and xenobiotics (light blue). (B) A volcano plot of the statistical
significance as indicated by P values (y-axis) associated with fold change in each metabolite (x-axis); baseline to CR (filled circles); CR to RF (open
circles). A large percentage of metabolites significantly increased (38%; n = 295) or decreased (39%; n = 300) upon CR. (C) A heatmap derived
from hierarchical clustering of the metabolomic data. Clustering was performed using complete linkage and Euclidean distance, where each
sample is a vector with all of the metabolite values. The color scale correlates with relative metabolite abundance across the samples: the black
indicates median value, red an elevation above the median, and green a decrease below the median.
4490 Collet et al Signature of Acute Caloric Restriction J Clin Endocrinol Metab, December 2017, 102(12):4486–4495
Downloaded from https://academic.oup.com/jcem/article-abstract/102/12/4486/4209888
by guest
on 26 February 2018
half-life (Supplemental Table 2), all other detected
endocannabinoids increased in CR then decreased upon
RF (Fig. 4E). These findings are consistent with experi-
mental evidence in animals where a key role for endog-
enous endocannabinoids is to stimulate food intake (24).
Amino acids and their derivatives
Several amino acids and their metabolites (in partic-
ular tryptophan and its derivatives) decreased in CR, then
increased with RF (Fig. 1C; Supplemental Table 2); these
changes may in part reflect reduced dietary intake. In
contrast, the three-branched chain amino acids (BCAAs),
leucine, isoleucine, and valine significantly increased
upon CR (all P # 1.4 3 1027; Fig. 5A). BCAAs are
degraded by the branched-chain a-keto acid de-
hydrogenase complex into acyl-CoA derivatives, which
are converted into acetyl-CoA or succinyl-CoA that enter
the TCA cycle. We observed increased levels of many
BCAA catabolites consistent with accelerated BCAA
catabolism under CR which reversed upon RF (Supple-
mental Fig. 2).
Steroid metabolism
In contrast to cortisol, which changes minimally with
age, circulating concentrations of the adrenal steroid
hormone DHEAS are high during early adulthood then
decline markedly with age (25). Some, but not all, studies
in primates and humans (26) have suggested that chronic
CR may affect DHEAS levels. In this study, 48 hours of
CR was associated with an increase in DHEAS and the
steroid hormones pregnenolone and androsterone; values
returned to baseline levels on RF (Fig. 5B; Supplemental
Fig. 3). Cortisol levels did not change significantly during
the study (Supplemental Table 2).
Discussion
Using an experimental design in which we stabilized
dietary intake across participants for 24 hours before an
observed period of acute CR, followed by ad libitum RF
to restore energy homeostasis, we identified a charac-
teristic metabolomic signature associated with acute CR.
Some of our findings alignwith previous studies that have
Figure 2. Glycolysis and gluconeogenesis. (A) Statistically significant increases (red) and decreases (green) in metabolites involved in glycolysis and
the TCA cycle with CR (black bars) and upon RF (white bars). Fold changes in glucose, pyruvate, and TCA cycle components are shown (y-axis).
Some metabolites were not measured in this assay (gray). Statistical significance is presented as follows: + for P values between 0.001 and 0.05;
* for P values # 0.001; ** for P values # 0.001 and q values # 0.001. (B) Fold changes in glucogenic amino acids and their N-acetyl-derivatives
during the study. Plots show mean 6 SEM of the eight subjects at baseline (BL; gray), CR (black), and RF (white).
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measured targeted sets of metabolites in response to an
overnight/prolonged fast (27, 28). Although changes in
glycolysis and markers of fatty acid b-oxidation were
predicted, our study shows that v-oxidation (generally
regarded as a minor fatty acid oxidation pathway in
humans) may be activated in response to acute CR in
healthy individuals. v-oxidation is used as part of the
compensation for defective b or a-fatty acid oxidation in
rare genetic disorders, such as Refsum disease and
X-linked adrenal leukodystrophy (29).
We saw consistent class-wide changes in several lipid
species (phospholipids, sphingolipids, and endocanna-
binoids), whichmay reflect the mobilization of fatty acids
for energetic purposes. In keeping with this hypothesis,
CR/RF induced changes in fatty acids correlated with
changes in their respective fatty acyl carnitines (Supple-
mental Fig. 4). Additionally, we observed a negative
correlation between the change in fatty acid levels and the
change in lysophosphatidylcholines with CR (Supple-
mental Fig. 5), an effect that may be mediated by neu-
ropathy target esterase-related esterase, an enzyme which
has lysophospholipase activity, is expressed in adipose
tissue and skeletal muscle, and is upregulated upon
fasting (30).
By focusing on the 27 long chain fatty acids and
polyunsaturated fatty acids examined in this study
(Fig. 3C), we observed that palmitoleate (16:1), a major
constituent of the glycerides in human adipose tissue that
has been associatedwith increased insulin sensitivity (31),
exhibited a highly significant change with CR (3.61-fold,
P = 1.9 3 1025). In contrast, arachidonate, a major v-6
fatty acid and precursor of lipid-derived mediators of
inflammation (leukotrienes and thromboxanes) changed
least in response to CR (Fig. 3C). Thus, although the
Figure 3. Fatty acid oxidation and lipolysis. (A) Metabolites involved in lipolysis and fatty acid oxidation that significantly increased (red) or
decreased (green) with CR. Some metabolites were not measured in this assay (gray). (B–D) Fold changes in (B) monoacylglycerols (MAG), (C)
medium and long-chain fatty acids, and (D) acylcarnitines (CAR) with CR (black) and RF (white). Lipid species are annotated using the following
convention: lipid class [number of carbon atoms]:[number of double bonds], [position of double bond(s) if known]. In addition, for MAG, sn1 or
sn2 indicate the esterification position in the glycerol backbone, which links the acyl group. Some fatty acids are also designated by abbreviations,
such as arachidonic acid (AA), docosahexaenoate (DHA), docosapentaenoate (DPA), and eicosapentaenoate (EPA). (E) Fold changes in ketone bodies
between baseline (BL), CR, and RF; mean 6 SEM. (F) Fold changes with CR (black) and RF (white) in other lipid species involved in fatty acid
oxidation. Statistical significance is presented as follows: + for P values between 0.001 and 0.05; * for P values # 0.001; ** for P values # 0.001
and q values # 0.001.
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whole scale changes in fatty acids we observed during CR
represent the activation of fatty acid oxidation to supply
energetic needs, specific changes in fatty acids may pre-
dispose to increased insulin sensitivity and reduced cel-
lular inflammation, findingswhich have potential relevance
to protection from aging (32, 33) and require further
exploration.
In this study, we identified a series of metabolite
changes associated with acute CR without weight loss.
The changes in carbohydrate, lipid, and amino acid
metabolism that we observed are characteristic of the
counter-regulatory response that acts to defend against
starvation and restore energy homeostasis. Although
this degree of CR is seldom experienced by most
people, short-term CR for weight loss engages the same
physiological and biochemical mechanisms. The acti-
vation of these mechanisms, whose function is to
restore energy balance, underpins weight regain, the
phenomenon popularly known as yo-yo dieting. The
application of metabolomics analyses to carefully
controlled studies of weight loss and the comparison
with the data set reported here, may reveal biomarkers
that predict the degree of weight loss/regain.
Experimental studies in animal models have con-
sistently shown that CR, typically 40% to 60% of
energy requirements, can extend lifespan by up to
50% compared with ad libitum fed animals (34–36).
Our study permits comparison with a large body of
research into the effects of CR in lower organisms,
although there are challenges in comparing data
across species and from serum rather than cells/
tissues (37, 38). One particularly interesting con-
vergence is the finding that some phosphatidyletha-
nolamines, lipids that are known to affect cell survival
Figure 4. Phospholipids and other lipid mediators. Fold changes in phospholipids and other lipid mediators with CR (black) and RF (white): (A)
glycerophospholipids, (B) plasmalogens, (C) lysophospholipids, and (D) sphingomyelins. The acyl group(s) are specified using the following
convention: [number of carbon atoms]:[number of double bonds], [position of double bond(s) if known]; or the total numbers if unknown. In
addition, for LPC and LPE, sn1 or sn2 indicate the esterification position in the glycerol backbone, which links the acyl group. PC(18:0/20:3)a and
PC(18:0/20:3)b are structurally similar but differ by the position of the double bonds. The precise structure of PC (38:5)a and PC(38:5)b could not
be specified. Statistical significance is presented as follows: + for P values between 0.001 and 0.05; * for P values # 0.001; ** for P values #
0.001 and q values # 0.001. (E) Fold changes in endocannabinoids between baseline (BL), CR, and RF; mean 6 SEM. LPC, lysophosphatidylcholine;
LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PPC, plasmalogen phosphatidylcholine; PPE,
plasmalogen phosphatidylethanolamine; SM, sphingomyelin.
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and the lifespan of yeast and flies (39), decreased with
CR and increased with RF.
In conclusion, we have shown that analysis of the
metabolome in a carefully conducted clinical study can
provide insights into the mechanisms underpinning
physiological processes, such as the response to acute CR
in humans. With replication, these studies have the po-
tential to provide valuable insights into the mechanisms
underlying the effects of CR, which may inform new
therapeutic opportunities for weight maintenance.
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